Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Barrett

Showing results (401-410 of 439) with videos related to

Pageof 44
Sort By:
Nature Communications|September 28, 2022
Activation of the human insulin receptor by non-insulin-related peptidesNicholas S Kirk, Qi Chen, Yingzhe Ginger Wu, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutionsDavid G Barrett, John G Catalano, David N Deaton, et al.
Vaccine|February 8, 2006
Immunization with fibrillar Abeta(1-42) in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain AbetaElizabeth Head, Edward G Barrett, M Paul Murphy, et al.
Electroencephalography and Clinical Neurophysiology. Supplement|January 1, 1996
Optic neuritis: swelling and atrophyB D Youl, G Turano, A D Towell, et al.
Endocrinology|May 28, 2005
A novel glucokinase activator modulates pancreatic islet and hepatocyte functionAlexander M Efanov, David G Barrett, Martin B Brenner, et al.
Kidney International Reports|December 22, 2025
Central Nervous System Iron Content in Pediatric CKDEmily J S Steinbach, Lucas D G Barrett, Chu-Yu Lee, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2006
Acyclic, orally bioavailable ketone-based cathepsin K inhibitorsDavid G Barrett, John G Catalano, David N Deaton, et al.
European Journal of Endocrinology|December 20, 2018
Causes, patterns and severity of androgen excess in 487 consecutively recruited pre- and post-pubertal childrenJan Idkowiak, Yasir S Elhassan, Pascoe Mannion, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2005
Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitorsDavid G Barrett, John G Catalano, David N Deaton, et al.
JAMA Network Open|May 10, 2024
Share of Adult Suicides After Recent Jail ReleaseTed R Miller, Lauren M Weinstock, Brian K Ahmedani, et al.
Pageof 44

Showing results (401-410 of 439) with videos related to

Sort By:
Pageof 44
Nature Communications|September 28, 2022
Activation of the human insulin receptor by non-insulin-related peptidesNicholas S Kirk, Qi Chen, Yingzhe Ginger Wu, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutionsDavid G Barrett, John G Catalano, David N Deaton, et al.
Vaccine|February 8, 2006
Immunization with fibrillar Abeta(1-42) in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain AbetaElizabeth Head, Edward G Barrett, M Paul Murphy, et al.
Electroencephalography and Clinical Neurophysiology. Supplement|January 1, 1996
Optic neuritis: swelling and atrophyB D Youl, G Turano, A D Towell, et al.
Endocrinology|May 28, 2005
A novel glucokinase activator modulates pancreatic islet and hepatocyte functionAlexander M Efanov, David G Barrett, Martin B Brenner, et al.
Kidney International Reports|December 22, 2025
Central Nervous System Iron Content in Pediatric CKDEmily J S Steinbach, Lucas D G Barrett, Chu-Yu Lee, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2006
Acyclic, orally bioavailable ketone-based cathepsin K inhibitorsDavid G Barrett, John G Catalano, David N Deaton, et al.
European Journal of Endocrinology|December 20, 2018
Causes, patterns and severity of androgen excess in 487 consecutively recruited pre- and post-pubertal childrenJan Idkowiak, Yasir S Elhassan, Pascoe Mannion, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2005
Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitorsDavid G Barrett, John G Catalano, David N Deaton, et al.
JAMA Network Open|May 10, 2024
Share of Adult Suicides After Recent Jail ReleaseTed R Miller, Lauren M Weinstock, Brian K Ahmedani, et al.
Pageof 44